Researcher.Life Logo

Infectious Agents and Cancer : Impact Factor & More

eISSN: 1750-9378pISSN: 1750-9378
JournalOpen Access

Key Metrics

CiteScore
4.5
Impact Factor
< 5
SJR
Q3Oncology
SNIP
0.88
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Infectious Agents and Cancer

Infectious Agents and Cancer Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • Scopus Scopus
  • DOAJ DOAJ
  • SJR SJR
Overview
Publisher BMC
Language English
Frequency Continuous publication
Article Processing ChargesEUR 2490 | USD 2990 | GBP 2190
Publication Time17
Editorial Review ProcessAnonymous peer review
General Details
LanguageEnglish
Society/Institute/SponsorAfrican Organization for Research and Training on Cancer (AORTIC)
FrequencyContinuous publication
Publication Start Year2006
Publisher URLVisit website
Website URLVisit website
Publication Details
PlagiarismVisit website
Publication Time 17
Waiver PolicyVisit website
Editorial Review Detail
Editorial TeamVisit website
Review ProcessAnonymous peer review
Review UrlVisit website
Information for authors
Author instructionsVisit website
Copyright DetailsVisit website
Deposit PolicySherpa/Romeo
License typeCC BY, CC0
OA statementVisit website
View less

Planning to publish in Infectious Agents and Cancer ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Infectious Agents and Cancer

CD44 expression associates with EBV LMP1, reduced CD8⁺ T cell infiltration, and lower PD-L1 combined positive score in nasopharyngeal carcinoma.
  • 29 Jun 2026
  • Infectious agents and cancer
Correlation between viral load and cervical squamous lesion severity in single and multiple infections: a large-scale analysis.
  • 23 Jun 2026
  • Infectious agents and cancer
Point-of-care hrHPV mRNA detection with reverse transcription recombinase polymerase amplification on a portable fluorimeter from provider-collected cervical samples in Maputo, Mozambique.
  • 23 Jun 2026
  • Infectious agents and cancer
Motivations and hesitations for cervical cancer screening: considerations for scale-up of human papilloma virus (HPV) testing within HIV care in Zimbabwe.
  • 19 Jun 2026
  • Infectious agents and cancer
Combined C-terminal truncation and point mutations in HBx in genotype D1 HBV-associated hepatocellular carcinoma.
  • 18 Jun 2026
  • Infectious agents and cancer
Acquired epidermodysplasia verruciformis presenting as isolated genital hypopigmentation in a renal transplant recipient: a rare case report.
  • 16 Jun 2026
  • Infectious agents and cancer
CD44 expression associates with EBV LMP1, reduced CD8⁺ T cell infiltration, and lower PD-L1 combined positive score in nasopharyngeal carcinoma.
  • 29 Jun 2026
  • Infectious agents and cancer
Correlation between viral load and cervical squamous lesion severity in single and multiple infections: a large-scale analysis.
  • 23 Jun 2026
  • Infectious agents and cancer
Point-of-care hrHPV mRNA detection with reverse transcription recombinase polymerase amplification on a portable fluorimeter from provider-collected cervical samples in Maputo, Mozambique.
  • 23 Jun 2026
  • Infectious agents and cancer
Motivations and hesitations for cervical cancer screening: considerations for scale-up of human papilloma virus (HPV) testing within HIV care in Zimbabwe.
  • 19 Jun 2026
  • Infectious agents and cancer
Combined C-terminal truncation and point mutations in HBx in genotype D1 HBV-associated hepatocellular carcinoma.
  • 18 Jun 2026
  • Infectious agents and cancer
Acquired epidermodysplasia verruciformis presenting as isolated genital hypopigmentation in a renal transplant recipient: a rare case report.
  • 16 Jun 2026
  • Infectious agents and cancer

FAQs on Infectious Agents and Cancer